Vir(VIR) - 2025 Q4 - Earnings Call Presentation

2026 Vir Biotechnology, Inc. 1 VIR-5500 Strategic Collaboration with Astellas and Positive Phase 1 Data February 23, 2026 2026 Vir Biotechnology, Inc. 2 Agenda Legal disclaimer Forward-Looking Statements Statements in this presentation that are not statements of historical fact are forward-looking statements. Such forward-looking statements include, without limitation, statements regarding: the therapeutic and commercial potential of VIR-5500 and other assets within its oncology solid tumor portfolio, precl ...